Fingerprint
Dive into the research topics where Kieko Kobayashi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
RASH3D19 mediates RAS activation through a positive feedback loop in KRAS-mutant cancer
Treekitkarnmongkol, W., Katayama, H., Sankaran, D., Tai, M. C., Rauth, S., Chen, H., Nguyen, T., Hara, K., Thege, F. I., Ponnusamy, M. P., Batra, S. K., Wang, H., Wistuba, I. I., Schmittgen, T. D., Heymach, J. V., Kopetz, S., Hu, T., Yao, W., Maitra, A. & Sen, S., Jan 2026, In: Nature cell biology. 28, 1, p. 197-206 10 p.Research output: Contribution to journal › Article › peer-review
1 Link opens in a new tab Scopus citations -
Continuous Androgen Deprivation Therapy with or Without Metastasis-directed Therapy for Oligometastatic Prostate Cancer: The Multicenter Phase 2 Randomized EXTEND Trial
Sherry, A. D., Siddiqui, B. A., Haymaker, C., Fellman, B. M., Medina-Rosales, M. N., Bathala, T. K., Wang, S., Liu, S., Seo, A., Hara, K., Lu, H., Troncoso, P., Chun, S. G., Ha, C. S., Mayo, L. L., Mok, H., Park, R. J., Chapin, B. F., Phillips, R. M. & Deek, M. P. & 11 others, , Nov 2025, In: European urology. 88, 5, p. 496-509 14 p.Research output: Contribution to journal › Article › peer-review
Open Access8 Link opens in a new tab Scopus citations -
Metastasis-directed radiotherapy without systemic therapy for oligometastatic clear-cell renal-cell carcinoma: primary efficacy analysis of a single-arm, single-centre, phase 2 trial
Tang, C., Sherry, A. D., Seo, A., Hara, K., Choi, H., Liu, S., Sun, X., Montoya, A., Ludmir, E. B., Shah, A. Y., Jonasch, E., Zurita, A. J., Kovitz, C., Alhalabi, O., Goswami, S., Hahn, A. W., Campbell, M. T., Hernandez, A., Nead, K. T. & Van Loo, P. & 10 others, , Oct 2025, In: The lancet oncology. 26, 10, p. 1289-1299 11 p.Research output: Contribution to journal › Article › peer-review
5 Link opens in a new tab Scopus citations -
CALML5 is a novel diagnostic marker for differentiating thymic squamous cell carcinoma from type B3 thymoma
Kanamori, K., Suina, K., Shukuya, T., Takahashi, F., Hayashi, T., Hara, K., Saito, T., Mitsuishi, Y., Shimamura, S. S., Winardi, W., Tajima, K., Ko, R., Mimori, T., Asao, T., Itoh, M., Kawaji, H., Suehara, Y., Takamochi, K., Suzuki, K. & Takahashi, K., Apr 2023, In: Thoracic Cancer. 14, 12, p. 1089-1097 9 p.Research output: Contribution to journal › Article › peer-review
Open Access11 Link opens in a new tab Scopus citations -
Clinical relevance of PD-L2 expression in surgically resected lung adenocarcinoma
Takamochi, K., Hara, K., Hayashi, T., Kohsaka, S., Takahashi, F., Suehara, Y., Shimokawa, M. & Suzuki, K., Jun 2022, In: Lung Cancer. 168, p. 50-58 9 p.Research output: Contribution to journal › Article › peer-review
9 Link opens in a new tab Scopus citations